Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RIOT vs GSK✓SelectedUSD · GSKRIOT vs GSK performance historyLatest closeAs of-2.63%11/16
Stock and ETF performance explorer

RIOT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+67.9%
GSK return
+64.4%
Excess return
+3.5%
Maximum drawdown
-66.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.6%-0.1%-2.5%-2.6%
7D-3.4%-1.3%-2.1%-3.5%
30D+24.3%+2.7%+21.6%+24.7%
3M-10.3%+2.7%-13.0%-9.9%
6M-27.4%+3.3%-30.7%-27.1%
YTD+34.6%+6.5%+28.2%+37.5%
1Y+22.3%+10.7%+11.6%+25.4%
3Y+67.9%+64.4%+3.6%+64.1%
All+67.9%+64.4%+3.5%+64.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling